资源类型：
收录情况：
◇ SCIE
◇ CPCI(ISTP)
文章类型：
作者：
Li, Dapeng[1]
*
;
Tang, Ping Zhang[2]
;
Chen, Xiaohong[3]
;
Ge, Minghua[4]
;
Zhang, Yuan[5]
;
Guo, Zhuming[6]
;
Wang, Jun[7]
;
Shi, Feng[8]
;
Zhang, Jiewu[9]
;
Cheng, Ying[10]
;
Li, Zhendong[11]
;
Liu, Hui[12]
;
Qin, Jianwu[13]
;
Huang, Rui[14]
;
Cheng, Ruochuan[15]
;
Xu, Zhengang[16,17]
;
Chi, Yihebali[16,17]
;
Zheng, Xiangqian[18]
;
Gao, Ming[1]
;
机构：
[1]Tianjin Med Univ, Canc Inst & Hosp, Tianjin, Peoples R China
[2]Chinese Acad Med Sci, Canc Hosp, Beijing, Peoples R China
[3]CMU, Beijing Tongren Hosp, Beijing, Peoples R China
首都医科大学附属北京同仁医院
首都医科大学附属同仁医院
[4]Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
浙江省肿瘤医院
[5]Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China
[6]Sun Yat Sen Univ, Ctr Canc, Guangzhou, Guangdong, Peoples R China
[7]Gansu Prov Canc Hosp, Lanzhou, Gansu, Peoples R China
[8]Hunan Canc Hosp, Changsha, Hunan, Peoples R China
[9]Harbin Med Univ, Affiliated Canc Hosp, Harbin, Heilongjiang, Peoples R China
[10]Jilin Prov Canc Hosp, Dept Oncol, Changchun, Jilin, Peoples R China
[11]Liaoning Canc Hosp & Inst, Shenyang, Liaoning, Peoples R China
[12]Fujian Canc Hosp, Fuzhou, Fujian, Peoples R China
[13]Henan Canc Hosp, Zhengzhou, Henan, Peoples R China
河南省肿瘤医院
[14]Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China
四川大学华西医院
[15]Kunming Med Univ, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China
昆明医科大学附属第一医院
[16]Chinese Acad Med Sci, Canc Hosp, Natl Canc Ctr, Beijing, Peoples R China
[17]Peking Union Med Coll, Beijing, Peoples R China
[18]Tianjin Univ, Canc Inst & Hosp, Tianjin, Peoples R China
ISSN：
被引次数：
WOS：
中科院(CAS)分区：
出版当年[2020]版：
大类
|
1 区
医学
小类
|
1 区
肿瘤学
最新[2023]版：
大类
|
1 区
医学
小类
|
1 区
肿瘤学
影响因子：
最新[2023版]
最新五年平均
出版当年[2019版]
出版当年五年平均
出版前一年[2018版]
出版后一年[2020版]
第一作者：
第一作者机构：
[1]Tianjin Med Univ, Canc Inst & Hosp, Tianjin, Peoples R China
推荐引用方式(GB/T 7714)：
Li Dapeng,Tang Ping Zhang,Chen Xiaohong,et al.Anlotinib treatment in locally advanced or metastatic medullary thyroid carcinoma: A multicenter, randomized, double-blind, placebo-controlled phase IIB trial[J].JOURNAL OF CLINICAL ONCOLOGY.2019,37(15):doi:10.1200/JCO.2019.37.15_suppl.6019.
APA：
Li, Dapeng,Tang, Ping Zhang,Chen, Xiaohong,Ge, Minghua,Zhang, Yuan...&Gao, Ming.(2019).Anlotinib treatment in locally advanced or metastatic medullary thyroid carcinoma: A multicenter, randomized, double-blind, placebo-controlled phase IIB trial.JOURNAL OF CLINICAL ONCOLOGY,37,(15)
MLA：
Li, Dapeng,et al."Anlotinib treatment in locally advanced or metastatic medullary thyroid carcinoma: A multicenter, randomized, double-blind, placebo-controlled phase IIB trial".JOURNAL OF CLINICAL ONCOLOGY 37..15(2019)
